Nanotechnology Now - News Story: Capsulution is Starting In-vivo Tests at Charité

Home > News > Capsulution is Starting In-vivo Tests at Charité

September 18th, 2006

Capsulution is Starting In-vivo Tests at Charité

Abstract:
The nanotechnology company Capsulution NanoScience AG (Berlin, Germany) has begun with pre-clinical in-vivo tests of innovative formulations of a hormone compound for tumor therapy.

Source:
pressebox.de

Bookmark:

Related Links

Capsulution NanoScience

Related News Press

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE